Increased susceptibility of Pseudomonas aeruginosa to macrolides and ketolides in eukaryotic cell culture media and biological fluids due to decreased expression of oprM and … JM Buyck, P Plésiat, H Traore, F Vanderbist, PM Tulkens, F Van Bambeke Clinical Infectious Diseases 55 (4), 534-542, 2012 | 109 | 2012 |
Outer membrane permeability: Antimicrobials and diverse nutrients bypass porins in Pseudomonas aeruginosa J Ude, V Tripathi, JM Buyck, S Söderholm, O Cunrath, J Fanous, B Claudi, ... Proceedings of the National Academy of Sciences 118 (31), e2107644118, 2021 | 67 | 2021 |
Pharmacodynamic evaluation of the intracellular activity of antibiotics towards Pseudomonas aeruginosa PAO1 in a model of THP-1 human monocytes JM Buyck, PM Tulkens, F Van Bambeke Antimicrobial agents and chemotherapy 57 (5), 2310-2318, 2013 | 64 | 2013 |
New amphiphilic neamine derivatives active against resistant Pseudomonas aeruginosa and their interactions with lipopolysaccharides G Sautrey, L Zimmermann, M Deleu, A Delbar, L Souza Machado, ... Antimicrobial agents and chemotherapy 58 (8), 4420-4430, 2014 | 57 | 2014 |
Quantitative contribution of efflux to multi-drug resistance of clinical Escherichia coli and Pseudomonas aeruginosa strains O Cunrath, DM Meinel, P Maturana, J Fanous, JM Buyck, P Saint Auguste, ... EBioMedicine 41, 479-487, 2019 | 46 | 2019 |
Salicylidene acylhydrazides and hydroxyquinolines act as inhibitors of type three secretion systems in Pseudomonas aeruginosa by distinct mechanisms A Anantharajah, JM Buyck, C Sundin, PM Tulkens, MP Mingeot-Leclercq, ... Antimicrobial agents and chemotherapy 61 (6), 10.1128/aac. 02566-16, 2017 | 40 | 2017 |
Inhibition of the Injectisome and Flagellar Type III Secretion Systems by INP1855 Impairs Pseudomonas aeruginosa Pathogenicity and Inflammasome Activation A Anantharajah, E Faure, JM Buyck, C Sundin, T Lindmark, J Mecsas, ... The Journal of infectious diseases 214 (7), 1105-1116, 2016 | 32 | 2016 |
Correlation between cytotoxicity induced by Pseudomonas aeruginosa clinical isolates from acute infections and IL-1β secretion in a model of human THP-1 … A Anantharajah, JM Buyck, E Faure, Y Glupczynski, ... Pathogens and disease 73 (7), ftv049, 2015 | 28 | 2015 |
Role of MexAB-OprM in intrinsic resistance of Pseudomonas aeruginosa to temocillin and impact on the susceptibility of strains isolated from patients suffering from … JM Buyck, S Guénard, P Plésiat, PM Tulkens, F Van Bambeke Journal of antimicrobial chemotherapy 67 (3), 771-775, 2012 | 28 | 2012 |
Activities of antibiotic combinations against resistant strains of Pseudomonas aeruginosa in a model of infected THP-1 monocytes JM Buyck, PM Tulkens, F Van Bambeke Antimicrobial agents and chemotherapy 59 (1), 258-268, 2015 | 26 | 2015 |
Clinical pharmacokinetics of daptomycin N Gregoire, A Chauzy, J Buyck, B Rammaert, W Couet, S Marchand Clinical Pharmacokinetics 60 (3), 271-281, 2021 | 25 | 2021 |
P. aeruginosa LPS stimulates calcium signaling and chloride secretion via CFTR in human bronchial epithelial cells JM Buyck, V Verriere, R Benmahdi, G Higgins, B Guery, R Matran, ... Journal of Cystic Fibrosis 12 (1), 60-67, 2013 | 24 | 2013 |
Semi-mechanistic PK/PD modelling of combined polymyxin B and minocycline against a polymyxin-resistant strain of Acinetobacter baumannii V Aranzana-Climent, JM Buyck, Y Smani, J Pachón-Diaz, S Marchand, ... Clinical Microbiology and Infection 26 (9), 1254. e9-1254. e15, 2020 | 23 | 2020 |
Caspase-1-driven neutrophil pyroptosis and its role in host susceptibility to Pseudomonas aeruginosa K Santoni, D Pericat, L Gorse, J Buyck, M Pinilla, L Prouvensier, ... PLoS pathogens 18 (7), e1010305, 2022 | 22 | 2022 |
In vitro models for the study of the intracellular activity of antibiotics JM Buyck, S Lemaire, C Seral, A Anantharajah, F Peyrusson, PM Tulkens, ... Bacterial Persistence: Methods and Protocols, 147-157, 2016 | 13 | 2016 |
Semimechanistic Pharmacodynamic Modeling of Aztreonam‐Avibactam Combination to Understand Its Antimicrobial Activity Against Multidrug‐Resistant Gram‐Negative Bacteria A Chauzy, B Gaelzer Silva Torres, J Buyck, B de Jonge, C Adier, ... CPT: pharmacometrics & systems pharmacology 8 (11), 815-824, 2019 | 12 | 2019 |
Pharmacodynamic modelling of β-lactam/β-lactamase inhibitor checkerboard data: illustration with aztreonam–avibactam A Chauzy, J Buyck, BLM de Jonge, S Marchand, N Grégoire, W Couet Clinical Microbiology and Infection 25 (4), 515. e1-515. e4, 2019 | 11 | 2019 |
Preclinical pharmacokinetic and pharmacodynamic data to support cefoxitin nebulization for the treatment of Mycobacterium abscessus S Mehta, V Aranzana-Climent, B Rammaert, N Grégoire, S Marchand, ... Antimicrobial agents and chemotherapy 63 (7), 10.1128/aac. 02651-18, 2019 | 10 | 2019 |
Bacterial Persistence: Methods and Protocols J Michiels, M Fauvart Humana Press, 2016 | 9 | 2016 |
Sequential time-kill, a simple experimental trick to discriminate between pharmacokinetics/pharmacodynamics models with distinct heterogeneous subpopulations versus homogenous … A Chauzy, H Ih, M Jacobs, S Marchand, N Grégoire, W Couet, JM Buyck Antimicrobial Agents and Chemotherapy 64 (8), 10.1128/aac. 00788-20, 2020 | 8 | 2020 |